AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 873,918 shares, an increase of 90.8% from the August 15th total of 458,107 shares. Based on an average daily volume of 476,023 shares, the short-interest ratio is presently 1.8 days. Currently, 3.5% of the shares of the company are sold short.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
Several hedge funds have recently made changes to their positions in the company. Crescent Grove Advisors LLC purchased a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 1st quarter valued at $6,614,000. PMV Capital Advisers LLC increased its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after acquiring an additional 30,234 shares during the last quarter. Worth Asset Management LLC raised its stake in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% in the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after acquiring an additional 5,190 shares during the period. Bank of New York Mellon Corp raised its stake in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after acquiring an additional 10,146 shares during the period. Finally, CoreCap Advisors LLC purchased a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter valued at about $36,000.
AGF U.S. Market Neutral Anti-Beta Fund Trading Up 0.4%
Shares of NYSEARCA:BTAL traded up $0.04 during mid-day trading on Tuesday, reaching $12.63. The company had a trading volume of 352,208 shares, compared to its average volume of 796,373. AGF U.S. Market Neutral Anti-Beta Fund has a one year low of $10.86 and a one year high of $16.14. The company’s 50-day moving average price is $12.05 and its 200-day moving average price is $12.44. The firm has a market cap of $318.40 million, a price-to-earnings ratio of 17.67 and a beta of -0.64.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
See Also
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
- Cashing in on the Qubit: NVIDIA Takes the Quantum Leap
- Ready to Rumble: Anthropic Rings the AI Bell
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
